English
  1. Home
  2. Stocks
  3. Pghl Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Procter & Gamble Health Share Price Procter & Gamble Health

    Mid Cap
    ₹4,709.35
    +46.95 (1.01%)
    12 May, 2024 21:42 BSE: 500126 NSE: PGHLISIN: INE199A01012

    Start SIP in Procter & Gamble Health

    Start SIP

    Procter & Gamble Health Performance

    Day Range

    • Low 4,652
    • High 4,729
    ₹ 4,709

    52 Week Range

    • Low 4,575
    • High 5,643
    ₹ 4,709
    • Open Price4,680
    • Previous Close4,662
    • Volume2429

    Procter & Gamble Health Share Price

    • Over 1 Month -2.03%
    • Over 3 Month -14.3%
    • Over 6 Month -9.6%
    • Over 1 Year -0.13%

    Procter & Gamble Health Key Statistics

    P/E Ratio 36.5
    PEG Ratio -3.3
    Market Cap Cr 7,817
    Price to Book Ratio 10.4
    EPS 137.9
    Dividend 5.3
    Relative Strength Index 44.43
    Money Flow Index 59.26
    MACD Signal -36.12
    Average True Range 103.95
    Procter & Gamble Health Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 252310305301321
    Operating Expenses Qtr Cr 185208216256243
    Operating Profit Qtr Cr 67102894580
    Depreciation Qtr Cr 77666
    Interest Qtr Cr 00000
    Tax Qtr Cr 1628221419
    Net Profit Qtr Cr 4772663059
    Sign Up to Know More
    IndicatorJun 2023
    Total Revenue Annual Cr 1,248
    Operating Expenses Annual Cr 905
    Operating Profit Annual in Cr 325
    Depreciation Cr 28
    Interest Annual Cr 1
    Tax Annual Cr 85
    Net Profit Annual Cr 229
    Sign Up to Know More
    IndicatorJun 2023
    Cash from Operating Activity Annual Cr 236
    Cash from Investing Activity Annual Cr -22
    Cash from Financing Annual Activity Cr -98
    Net Cash Flow Annual Cr 116
    Sign Up to Know More
    IndicatorJun 2023
    Total ShareHolders Funds Annual Cr 751
    Fixed Assets Annual Cr 176
    Total Non Current Assets Annual Cr 305
    Total Current Assets Annual Cr 796
    Total Assets Annual Cr 1,101
    Sign Up to Know More
    IndicatorJun 2023
    Book Value Per Share Annual Rs 452
    ROE Annual % 31
    ROCE Annual % 40
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 28
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    Sign Up to Know More
    IndicatorJun 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    Sign Up to Know More
    IndicatorJun 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    Sign Up to Know More
    IndicatorJun 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    Sign Up to Know More
    IndicatorJun 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin %
    Sign Up to Know More
    Invest in Procter & Gamble Health

    Procter & Gamble Health Technicals

    EMA & SMA

    Current Price
    ₹4,709.35
    +46.95 (1.01%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹4,753.84
    • 50 Day
    • ₹4,843.27
    • 100 Day
    • ₹4,933.19
    • 200 Day
    • ₹4,960.41
    • 20 Day
    • ₹4,741.35
    • 50 Day
    • ₹4,854.07
    • 100 Day
    • ₹4,994.16
    • 200 Day
    • ₹5,055.02

    Procter & Gamble Health Resistance and Support

    PIVOT
    ₹4,696.79
    Resistance
    First Resistance 4,741.57
    Second Resistance 4,773.78
    Third Resistance 4,818.57
    RSI 44.43
    MFI 59.26
    MACD Single Line -36.12
    MACD -33.52
    Support
    First Resistance 4,664.57
    Second Resistance 4,619.78
    Third Resistance 4,587.57

    Procter & Gamble Health Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 2,558 157,010 61.38
    Week 17,641 1,457,709 82.63
    1 Month 13,021 873,991 67.12
    6 Month 18,319 1,330,850 72.65

    Procter & Gamble Health Result Highlights

    Procter & Gamble Health Synopsis

    NSE-Medical-Generic Drugs

    P&G Health is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1229.62 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2023. Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726.
    Market Cap 7,817
    Sales 1,169
    Shares in Float 0.80
    No of funds 143
    Yield 2.11
    Book Value 10.41
    U/D Vol ratio 0.4
    LTDebt / Equity
    Alpha -0.01
    Beta 0.22

    Procter & Gamble Health

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 51.82%51.82%51.82%51.82%
    Mutual Funds 9.86%8.98%8.41%8.1%
    Insurance Companies 3.55%3.41%3.71%4.08%
    Foreign Portfolio Investors 6.24%7.6%7.38%7.15%
    Financial Institutions/ Banks
    Individual Investors 22.61%22.9%23.44%23.64%
    Others 5.92%5.29%5.24%5.21%

    Procter & Gamble Health Management

    Name Designation
    Mr. Suresh Talwar Chairman & Ind.Director
    Mr. Milind Thatte Managing Director
    Mr. Lokesh Chandak Executive Director & CFO
    Ms. Seema Sambasivan Non Executive Director
    Mr. Aalok Agrawal Non Executive Director
    Mrs. Rani Jadhav Independent Director
    Mr. S Madhavan Independent Director

    Procter & Gamble Health Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Procter & Gamble Health Corporate Action

    Date Purpose Remarks
    2024-05-02 Quarterly Results
    2024-02-06 Quarterly Results & Interim Dividend
    2023-11-03 Quarterly Results
    2023-08-23 Audited Results & Final Dividend
    2023-05-15 Quarterly Results
    Date Purpose Remarks
    2024-02-14 INTERIM Rs.50.00 per share(500%)Interim Dividend
    2024-02-14 SPECIAL Rs.150.00 per share(1500%)Special Dividend
    2023-02-13 INTERIM Rs.45.00 per share(450%)Interim Dividend
    2022-05-13 INTERIM Rs.41.00 per share(410%)Interim Dividend

    Procter & Gamble Health MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 45,749
    HDFC Small Cap Fund Growth 29,685
    ICICI Prudential Smallcap Fund Growth 7,659
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3,835
    Aditya Birla Sun Life MNC Fund Payout Inc Dist cum Cap Wdrl 3,492

    Procter & Gamble Health FAQs

    What is Share Price of Procter & Gamble Health ?

    Procter & Gamble Health share price is ₹4,709 As on 12 May, 2024 | 21:28

    What is the Market Cap of Procter & Gamble Health ?

    The Market Cap of Procter & Gamble Health is ₹7817.2 Cr As on 12 May, 2024 | 21:28

    What is the P/E ratio of Procter & Gamble Health ?

    The P/E ratio of Procter & Gamble Health is 36.5 As on 12 May, 2024 | 21:28

    What is the PB ratio of Procter & Gamble Health ?

    The PB ratio of Procter & Gamble Health is 10.4 As on 12 May, 2024 | 21:28

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.